Article
Fierce JPM Week: How 23andMe plans to harness its massive database to further its ambitions in drug development
Rating:
0.0
Views:
63
Likes:
1
Library:
1
Drug development is expensive, can take years to complete and doesn't guarantee a novel therapy for treating disease. But consumer genetic testing company 23andMe is forging ahead to leverage its massive database of genetic data for research and to make and sell its own therapies.
Rate This Post
Rate The Educational Value
Rate The Ease of Understanding and Presentation
Interesting or Boring? Rate the Entertainment Value